Adrenocorticotropin binding sites in the rat median eminence have been localized in vivo. These binding sites occur in the basalar zone, which is rich in axonal endings. Using competitive binding and quantitative light-microscope radioautography, we found that the median-eminence binding site, in contradistinction to the adrenal receptor, binds specifically the residue 4-10 region of the adrenocorticotropin molecule. Using quantitative electron-microscope radioautography and median-eminence deafferentation, we localized the binding sites to axon terminals in this region. In time-delayed uptake studies using light-microscope radioautography, we failed to observe concentration of radiolabel in neurons of the medial basal hypothalamus after the direct injection of radioiodinated adrenocorticotropin(1-24) into the median eminence.
Binding sites for blood-borne adrenocorticotropin (ACTH) have been localized to the rat median eminence by quantitative radioautography (1) . The median eminence is one of the four circumventricular organs of the brain, which are targets for direct interaction with a variety of circulating peptide hormones (2) . Of these four regions, the median eminence is the only brain region in which specific binding sites for blood-borne adrenocorticotropin have been demonstrated (1) . In view of the various purportedly direct effects of blood-borne adrenocorticotropin and related peptides on brain function (3, 4) , we have attempted to determine the cellular location and binding specificity of adrenocorticotropin binding sites in the rat median eminence by using quantitative light-and electron-microscope radioautography. In addition, we report the results of pilot radioautographic investigations of brain uptake of circulating adrenocorticotropin (5) (6) (7) (8) .
METHODS
Synthetic ACTH1-24 (Cortrosyn), a gift from Organon, was iodinated using lactoperoxidase under mild conditions for 30 sec, as described by McIlhinney and Schulster (8) . Monoiodinated hormone prepared by this method has been shown to retain its steroidogenic properties and capacity to bind receptors isolated from rat adrenocortical cells (8) . lodinated peptide was purified by the silicic acid adsorption method of Rees et al. (9) with minor modifications, as follows. Ten milligrams of silicic acid (Bio-Sil A, mesh 200-325, Bio-Rad), which had been suspended in 2 ml of 50 mM sodium phosphate buffer, pH 7.4, containing 1.5% (wt/vol) bovine serum albumin, was added to the iodination mixture to terminate the iodination reaction. After 30 min at room temperature, the pellet was washed three times with 2 ml of cold distilled water and once with 1 M HCl. The adsorbed hormone was eluted in 2 ml of acetone/water/acetic acid (40:59:1, vol/vol) and concentrated by evaporation under a stream of N2. The purified 125I-labeled ACTH1-24 (125I-ACTH1-24) had a specific activity of 124 ,uCi/,g (1 Ci = 37 GBq). After purification, >98% of the radioactivity could be adsorbed by silicic acid and >95% could be precipitated by 10% (wt/vol) trichloroacetic acid. The labeled hormone retained its immunologic activity, as judged by its specific binding to a high-affinit antiserum (A-7) against the steroidogenic region of ACTH1-4 (10) .
To visualize binding sites for blood-borne adrenocorticotropin by light-microscope radioautography, 125I-ACTH1-24 (12) . Radioautographs were exposed in the dark at 40C for 4 days before development for 6 min in fresh Kodak D-170 solution.
For electron-microscope radioautography, trimmed coronal blocks of median eminence were post-fixed in 2% (wt/vol) OS04 in 0.1 M cacodylate buffer for 4 hr, dehydrated, and embedded in Epon. Thin sections (pale gold interference color) of median eminence were covered with a monolayer of Ilford L-4 emulsion (Ilford, Toronto) and exposed for 4 months before development in fresh Kodak D-19 (13) . Radioautographs were immersed in isoamyl acetate (Tousimis, Montreal) for 10 min, post-stained in uranyl acetate and lead citrate, and examined in a Hitachi HS-7S electron microscope.
The quantitation of light-microscope radioautographic reactions was accomplished with the aid of a Diavar photomicroscope (Reichert, Vienna) fitted with an 11 x 11 mm ocular grid frame (Whipple, Natick, MA). The average reaction intensity (silver grains per unit area) over the median eminence in each rat was quantitated by counting the number of grains observed within a total of 14 unit areas at a total magnification of x 1600. Unstained sections served to confirm the absence of spurious chemographic artifacts, and stained sections from a nonradioactive brain showed an insignificant level of background fog.
All grain views in the electron microscope were photographed and enlarged to a final magnification of x25,000. The relative contents of label in neuronal and glial structures were analyzed by allocating and tabulating grains according to the underlying structure (direct scoring) and by application of a 100-nm-radius resolution circle (14) to evaluate the degree of ambiguity in grain localization. Labeled nerve terminals were further categorized according to the ratio of clear and dense-core vesicles that they contained.
Confirmation of the localization obtained by electron microscopic analysis was sought in animals with introduced brain lesions. Four adult male Sprague-Dawley rats were placed in a stereotaxic apparatus, and the median eminence of each rat was deafferented unilaterally from the hypothalamus by hemicircular rotation of an extrudable Halasz-type knife, as previously described (15) . Two weeks after placement of the knife cuts, the rats were injected intracardially with 125I-ACTlH-24 (1.0 x 108cpm), either alone (2 rats) or with 50 pg of unlabeled ACTH1-24 (2 rats). Light-microscope radioautographs of coronal sections through the center of the median eminence were prepared as above. The average intensity of radioautographic reactions over that aspect of the median eminence ipsilateral to the deafferentation was compared to the intensity of the reactions over the contralateral aspect with intact axonal connections with the hypothalamus, by methods described previously (15) . In each rat median eminence, 32 unit areas were scored from the deafferented and the intact side, respectively.
Direct injections of peptides into the median eminence were done in the following manner (16) . Male Sprague-Dawley rats were anesthetized with an intraperitoneal injection of urethane (25% wt/vol solution; 1.25 g/kg) and secured in a stereotaxic apparatus. Body temperature was maintained at 38.5°C, and the heart rate was monitored continuously during the experiment. The hypothalamus was exposed via a transpharyngeal approach. Bleeding during surgery was controlled by insertion of a mixture of nontoxic Plasticine in Vaseline into the diplopic spaces occupied by venous sinuses. A glass micropipette with a tip diameter of -10 ,um and bent at a 15-20°angle within 2 mm of the tip was glued onto the needle of a 10-1.l Hamilton syringe containing 1251_ ACTH1-24 ( (18), during which the rats remained anesthetized and were periodically monitored in the stereotaxic apparatus, the rats were fixed by perfusion through the heart with Bouin's solution. Coronal blocks of medial basal hypothalamus were sectioned at 50-gm intervals at the level of the arcuate nucleus. Mounted and stained 5-Am-thick sections were radioautographed as described above, using a 2-month exposure.
RESULTS
The peptide specificity of adrenocorticotropin binding sites was compared in the median eminence and adrenal zona fasciculata ( Fig. 1 A and B) . Whereas a 1000-fold molar excess of coinjected unlabeled ACTH1-24 markedly blocked the binding of 125I-ACTH1-24 in both median eminence and adrenal, a 1000-fold molar excess of a-or p3-MSH blocked binding to the median eminence but not to the adrenal. The inhibition of 125I-ACTH1-24 binding to median eminence was compared at several concentrations of unlabeled ACTH124 a-MSH, and 8-LPH (Fig. 2) . On a molar basis, ACTH1-24 was consistently more effective than a-MSH, which in turn was more effective than ,B-LPH.
In electron-microscope radioautographs of the median eminence of rats injected intracardially with 125I-ACTH1-24 5 min prior to brain fixation, three-fourths of the bound radiolabel was localized to nerve terminals and preterminal axons (Table 1 and Fig. 3 ). Classification of labeled terminals according to vesicle content showed a nonrandom association: 65% of the labeled terminals contained a mixed population of clear and dense-core vesicles in a ratio of 1:1 to 10:1 (Fig. 4) . In electron-microscope radioautographs of rats coinjected with a 1000-fold excess of unlabeled ACTH1-24, the reverse situation was obtained, i.e., three-fourths of the residual bound radiolabel was localized to glia (Table 1) . Classification of the few nerve terminals that bound label in the presence of receptor blockade revealed a more randomized association, in that they contained pure vesicle populations or various mixtures of vesicle types without a dominant vesicle population ratio (Fig. 4) .
Hemicircular axonal deafferentiation of the median eminence produced a striking unilateral loss of total binding (Fig. 5) , but no significant change in nonspecific binding (Fig. 6) . In both rats, unilateral deafferentiation resulted in 50-60% loss of specific binding capacity.
Discrete cellular uptake of radiolabel was observed in light-microscope radioautographs of the medial basal hypothalamus of rats 8 hr after the median eminence was injected with 125I-WGA. In agreement with previous reports of the localization of tuberoinfundibular neurons by mapping with retrogradely transported morphologic markers (18, 19) , we observed labeled neurons restricted to the supraoptic, paraventricular, arcuate, and ventromedial nuclei, where the few retrogradely labeled neurons were concentrated in the posterior ventrolateral subdivision (20) (Fig. 7) . In our rats, an average of 1-3 labeled cells per tissue section was observed throughout the rostrocaudal extent of the arcuate nucleus. In peptide sequence. Presumably the adrenal binding sites recognize a longer portion of ACTH124, which is the core for full steroidogenic activity (24) .
Nerve terminals and preterminal axons in the median eminence appear to possess sites of specific binding, because the heavy labeling of these structures by 125I-ACTH1-24 is blocked by coinjected unlabeled ACTH1-24, and axonal deafferentiation of the median eminence greatly reduced specific binding. Labeled (18, 19) . Indeed, tuberoinfundibular neurons appear to have the capacity to take up and concentrate other circulating proteins and polypeptides (18, 19) . This capacity has been cited in support of a theory that would account for the presence of adrenocorticotropin and related peptides in arcuate hypothalamic neurons on the basis of direct uptake from the portal blood (1, (5) (6) (7) . Under our experimental conditions, however, we could not provide radioautographic evidence to support the uptake hypothesis with regard to adrenocorticotropin. This failure may reflect unexpected complications, such as selection of an inappropriate interval for uptake, enzymatic deiodination resulting in the loss of the radiolabel, and damage to axon terminals during injection. More likely, adrenocorticotropin is not handled by the hypothalamus in the same manner in vivo as are certain morphologic markers.
Previously tion of peptide-hormone binding sites to nerve terminals in the median eminence and, at least in the case of insulin, the hormone-receptive nerve terminals involved tuberoinfundibular neurons in the median basal hypothalamus (15) . Van Houten and Posner (25) have speculated that there exists a system of hormone-receptive neurons in and about the four circumventricular organs that function to relay endocrine information to the appropriate regulatory neurons behind the blood-brain barrier. The present localization of NH2-terminal-specific binding sites for blood-borne adrenocorticotropin to nerve terminals in the median eminence provides further support for the concept that the circumventricular organs function as the major, if not exclusive, sites of direct neuronal feedback for blood-borne peptide hormones.
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